| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |